Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Journal D'Urologie|January 1, 1989
[Unilateral primary vesico-ureteral reflux: uni- or bilateral reimplantation?]C Laurenti, C De Dominicis, F Iori, et al.Journal of Endourology|February 1, 1994
Scrotoscopy: a promising future? Our preliminary experienceG Franco, A Rocchegiani, C De Dominicis, et al.British Journal of Urology|May 1, 1991
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder exstrophy. A prospective studyA Marcheggiano, C Iannoni, G Latella, et al.Metabolism: Clinical and Experimental|December 27, 2018
Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB)Meera Shah, Marcello C Laurenti, Chiara Dalla Man, et al.Urologia Internationalis|October 13, 2001
Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspectsF Iori, C De Dominicis, M Liberti, et al.American Journal of Physiology. Endocrinology and Metabolism|November 2, 2020
Assessment of individual and standardized glucagon kinetics in healthy humansMarcello C Laurenti, Adrian Vella, Jon D Adams, et al.American Journal of Physiology. Endocrinology and Metabolism|March 12, 2026
Integrated Glucagon Model for Estimation of Alpha-cell Responsivity to Glucose and Amino Acids During Graded Glucose InfusionFederica Boscolo, Sneha Mohan, Marcello C Laurenti, et al.American Journal of Physiology. Endocrinology and Metabolism|December 9, 2024
Enhanced quantification of α-cell suppression by hyperglycemia using a high-sensitivity glucagon assayRoy B Dyer, Marcello C Laurenti, Hannah E Christie, et al.Diabetes|December 23, 2022
The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin SecretionRahele A Farahani, Aoife M Egan, Andrew A Welch, et al.European Journal of Clinical Investigation|December 8, 2020
Limitations of the fasting proinsulin to insulin ratio as a measure of β-cell health in people with and without impaired glucose toleranceAoife M Egan, Marcello C Laurenti, Maria Daniela Hurtado Andrade, et al.Pageof 7